Bill

Bill > S1481


MA S1481

To restore integrity in the marketing of pharmaceutical products and medical devices


summary

Introduced
03/29/2021
In Committee
03/29/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

For legislation to restore integrity in the marketing of pharmaceutical products and medical devices. Public Health.

AI Summary

This bill aims to restore integrity in the marketing of pharmaceutical products and medical devices. It does this by prohibiting pharmaceutical or medical device manufacturer agents from offering or giving gifts of any value to healthcare practitioners, their families, employees, or affiliated facilities. The bill also requires pharmaceutical and medical device manufacturing companies to publicly disclose any payments, subsidies, or other economic benefits they provide to healthcare practitioners, facilities, and other authorized entities. Additionally, the bill mandates the licensing and training of pharmaceutical and medical device manufacturer agents, with fees from the licensing process to be used for administering and enforcing the law. The Department of Public Health, in consultation with relevant medical boards, will be responsible for promulgating regulations and overseeing compliance, with the Attorney General's office also having enforcement authority.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Accompanied a study order, see S2772 (on 03/17/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...